During the past decade, Azienda Ospedaliera di Padova; Centro Emofilia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera di Padova; Centro Emofilia" are "Haemophilia A" (1 trials), "Hemophilia A" (1 trials), "Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor" (1 trials) and "Severe Hereditary Factor VIII Deficiency Disease Without Inhibitor" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera di Padova; Centro Emofilia" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera di Padova; Centro Emofilia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (1 trials) and "Standard of Care for Haemophilia A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera di Padova; Centro Emofilia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera di Padova; Centro Emofilia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Azienda Ospedaliera di Padova; Centro Emofilia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera di Padova; Centro Emofilia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".